Edward M. MD Kaye
CIK 1522780 · CEO · last filed 2026-07-16
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$5.71M
Companies
6
Total Filings
130
Lifetime Open-Market Net
-$18.32M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| CYTK | Director | 10,434 | $76.76 | $800.9K | -$5.51M | 51 | 2026-07-16 |
| STOK | Director | 110,874 | $32.71 | $3.63M | -$8.05M | 36 | 2026-06-05 |
| Avidity Biosciences, Inc. (RNAM) Delisted | Director | 0 | — | — | $0 | 1 | 2026-02-27 |
| RNA | Director | 6,692 | $12.34 | $82.6K | $0 | 5 | 2025-06-12 |
| SRPT | President & CEO | 71,229 | $16.78 | $1.20M | -$4.77M | 22 | 2017-08-07 |
| Sarepta Therapeutics, Inc. (AVII) Delisted | SVP & Chief Medical Officer | — | — | — | $0 | 2 | 2012-04-25 |
Recent Filings · Page 12 of 13
130 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2016-10-24 | SRPT | Tax (F) | −4,348 | -$213.3K | EDGAR |
| 2016-09-26 | SRPT | Mixed | — | -$2.08M | EDGAR |
| 2016-09-21 | SRPT | Mixed | — | -$1.05M | EDGAR |
| 2016-09-16 | SRPT | Sell (S) | −24,557 | -$736.7K | EDGAR |
| 2016-09-02 | SRPT | Tax (F) | −1,487 | -$38.8K | EDGAR |
| 2016-07-22 | SRPT | Tax (F) | −3,001 | -$67.4K | EDGAR |
| 2016-07-05 | CYTK | Grant (A) | — | $0 | EDGAR |
| 2016-05-20 | CYTK | Grant (A) | — | $0 | EDGAR |
| 2016-04-22 | SRPT | Tax (F) | −3,001 | -$59.1K | EDGAR |
| 2016-03-02 | SRPT | Grant (A) | −4,704 | $0 | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.